Skip to Content

barr 956 (Dextroamphetamine Sulfate Extended Release 15 mg)

Pill with imprint barr 956 is Brown, Capsule-shape and has been identified as Dextroamphetamine Sulfate Extended Release 15 mg. It is supplied by Teva Pharmaceuticals USA.

Dextroamphetamine is used in the treatment of adhd; narcolepsy and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dextroamphetamine 15 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for barr 956

Dextroamphetamine sulfate extended release 15 mg barr 956
Dextroamphetamine sulfate extended release 15 mg barr 956
Dextroamphetamine sulfate extended release 15 mg barr 956

Dextroamphetamine Sulfate Extended Release

Imprint
barr 956
Strength
15 mg
Color
Brown
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cns stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00555-0956
Inactive Ingredients
silicon dioxide, dibutyl sebacate, methylcellulose (15 mPa.s), povidone k30, propylene glycol, sucrose, corn starch, magnesium silicate, ferrosoferric oxide, ferric oxide red, titanium dioxide, ferric oxide yellow, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, indigotindisulfonate sodium, FD&C Red No. 40, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.